Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank71
5Y CAGR-64.2%
Studio
Year-over-Year Change

Year-over-year book value per share growth

5Y CAGR
-64.2%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202513.13%
2024337.38%
2023-68.50%
2022-32.89%
2021-0.12%
20202244.12%
2019165.39%
2018-104.03%
2017-25.87%
2016-32.26%